Search bioRxiv⌕ Search

Biology subjects

Reynolds, D. E.

Publications and source records attributed to Reynolds, D. E..

3 recordsLinked to original sources

Live Droplet Single-Cell RNA Sequencing

Single-cell RNA sequencing has emerged as one of the most influential methods of the past decade, enabling the dissection of cellular heterogeneity and the discovery of rare cell types. However, most workflows require cell lysis and provide only terminal snapshots, limiting their ability to capture dynamic cellular trajectories and temporal variations within the same cell. Herein, we present Live Droplet single-cell RNA sequencing (Live D-seq), a technology that enables scalable transcriptome-wide profiling of individual living cells over time. Live D-seq combines longitudinal intracellular sampling of live, barcoded cells with particle-templated emulsification and barcoded hydrogel beads, enabling repeated samples from the same cell lineage to be linked across time points. We showcase Live D-seq's capabilities by (i) demonstrating minimal cross-contamination in cross-species experiments, (ii) precisely mapping cellular barcodes to hydrogel bead barcodes, and (iii) tracking epithelial-to-mesenchymal transition dynamics in A549 cells over time. Altogether, Live D-seq enables repeated, non-destructive measurements of gene expression in the same single cells, offering a framework to study longitudinal single-cell biology in health and disease.

bioengineering↗

Live Spatial Transcriptomics Enables Longitudinal Tissue Mapping

Spatial transcriptomics has become an important technology in biomedical research by preserving the spatial context of gene expression in tissues and enabling the study of cellular states and interactions in situ. However, most existing methods provide only static snapshots of individual tissue specimens, requiring inference of the molecular dynamics underlying development, disease progression, and therapeutic response from different specimens rather than direct tracking in the same living tissue. Here, we introduce Live Spatial Transcriptomics (Live-ST), a technology that enables longitudinal, transcriptome-wide profiling of living tissue. Live-ST combines electroporation-based intracellular sampling and spatial barcoding to enable repeated, spatially resolved mRNA measurements in intact living tissue through next-generation sequencing. We demonstrate its capabilities by (i) benchmarking spatial mRNA capture in patterned two-dimensional cell systems, (ii) spatially profiling transcriptomes in intact, patient-derived living melanoma tissues while preserving tissue viability, and (iii) longitudinally tracking drug-response dynamics within the tumor microenvironment. Together, Live-ST enables repeated, non-destructive measurements of spatial gene expression, providing a new framework for studying dynamic tissue biology in native physiological and pathological contexts.

bioengineering↗

Maternally administered naltrexone and its major active metabolite 6β-naltrexol transport across the placental barrier in vitro

Opioid use disorder (OUD) has become a growing concern in the U.S. and has been a dominant presence among pregnant women, resulting in an unprecedented amount of prescription medications, particularly naltrexone (NTX), prescribed for pregnant women. Because of unknown potential harm that NTX can impose on the fetus and its premature brain, the needs for safety and regulation of NTX are still undetermined. To address this issue, a microfluidic device is fabricated to mimic structural phenotypes and physiological characteristic of an in vivo placental barrier to evaluate near-transport simulations of NTX and its primary metabolite, 6{beta}-naltrexol, across the placental barrier. Following transport analysis, cell layers are evaluated for possible gene-expressions released by an in vivo human placenta during NTX and 6{beta}-naltrexol placental exposure. When a 100 ng/mL dose of NTX and 6{beta}-naltrexol (1:1) is administered to the maternal channel, the mean fetal concentration for co-culture models exhibited ~2.5 % of NTX and ~2.2% of 6{beta}-naltrexol of the initial maternal concentration. To prototype and simulate fetal-brain exposure, perfusate from a fetal channel is directed to cultured N27 cells that are then evaluated for gene-expression.

bioengineering↗